Radiology Business November 5, 2024
Marty Stempniak

The Medicare program on Friday finalized plans to boost payment for certain diagnostic imaging agents delivered in the hospital outpatient setting.

First outlined in July, CMS is now moving forward with a proposal to issue separate payment for radiopharmaceuticals—a change long lobbied for by the imaging industry. For years, the agency has packaged payment for nuclear imaging agents with the procedure. However, this can create a barrier for those who require newer radiopharmaceuticals, advocates note.

Beginning Jan. 1, CMS will pay separately for diagnostic imaging agents with per-day costs above a threshold of $630. The Society of Nuclear Medicine & Molecular Imaging applauded the announcement Friday.

“This decision is a critical victory for patients who need advanced diagnostic...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Insurance, Medicare, Provider, Radiology
CMS Launches New Program for Mental Health, OUD Treatment
How Medicare Negotiated Drug Prices Compare to Other Countries
Telehealth groups call for urgent action as Medicare flexibility deadline looms
Innovating Without Compromising Integration: Considerations For Medicare
How the Federal Government Could Push People Toward Medicare Advantage – And Replace Traditional Medicare

Share This Article